Search Results - "Cascallò, Manel"

Refine Results
  1. 1

    A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients by García, Margarita, Moreno, Rafael, Gil-Martin, Marta, Cascallò, Manel, de Olza, Maria Ochoa, Cuadra, Carmen, Piulats, Josep Maria, Navarro, Valentin, Domenech, Marta, Alemany, Ramon, Salazar, Ramon

    Published in Human gene therapy (01-03-2019)
    “…Oncolytic viruses represent a unique type of agents that combine self-amplification, lytic, and immunostimulatory properties against tumors. A local and…”
    Get more information
    Journal Article
  2. 2

    Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression by Rodríguez-García, Alba, Giménez-Alejandre, Marta, Rojas, Juan J, Moreno, Rafael, Bazan-Peregrino, Miriam, Cascalló, Manel, Alemany, Ramon

    Published in Clinical cancer research (15-03-2015)
    “…Tumor targeting upon intravenous administration and subsequent intratumoral virus dissemination are key features to improve oncolytic adenovirus therapy…”
    Get full text
    Journal Article
  3. 3

    Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth by Guedan, Sonia, Rojas, Juan José, Gros, Alena, Mercade, Elena, Cascallo, Manel, Alemany, Ramon

    Published in Molecular therapy (01-07-2010)
    “…Successful virotherapy requires efficient virus spread within tumors. We tested whether the expression of hyaluronidase, an enzyme which dissociates the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    A pRb-responsive, RGD-modified, and Hyaluronidase-armed Canine Oncolytic Adenovirus for Application in Veterinary Oncology by Laborda, Eduardo, Puig-Saus, Cristina, Rodriguez-García, Alba, Moreno, Rafael, Cascalló, Manel, Pastor, Josep, Alemany, Ramon

    Published in Molecular therapy (01-05-2014)
    “…Human and canine cancer share similarities such as genetic and molecular aspects, biological complexity, tumor epidemiology, and targeted therapeutic…”
    Get full text
    Journal Article
  7. 7

    The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma by Martínez-Vélez, Naiara, Xipell, Enric, Vera, Beatriz, Acanda de la Rocha, Arlet, Zalacain, Marta, Marrodán, Lucía, Gonzalez-Huarriz, Marisol, Toledo, Gemma, Cascallo, Manel, Alemany, Ramón, Patiño, Ana, Alonso, Marta M

    Published in Clinical cancer research (01-05-2016)
    “…Osteosarcoma is the most common malignant bone tumor in children and adolescents. Despite aggressive chemotherapy, more than 30% of patients do not respond and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Adenovirus i-Leader Truncation Bioselected Against Cancer-associated Fibroblasts to Overcome Tumor Stromal Barriers by Puig-Saus, Cristina, Gros, Alena, Alemany, Ramon, Cascalló, Manel

    Published in Molecular therapy (01-01-2012)
    “…Tumor-associated stromal cells constitute a major hurdle in the antitumor efficacy with oncolytic adenoviruses. To overcome this biological barrier, an in…”
    Get full text
    Journal Article
  10. 10

    Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01 by Vera, Beatriz, Martínez-Vélez, Naiara, Xipell, Enric, Acanda de la Rocha, Arlet, Patiño-García, Ana, Saez-Castresana, Javier, Gonzalez-Huarriz, Marisol, Cascallo, Manel, Alemany, Ramón, Alonso, Marta M

    Published in PloS one (01-01-2016)
    “…Despite the recent advances in the development of antitumor therapies, the prognosis for patients with malignant gliomas remains dismal. Therapy with…”
    Get full text
    Journal Article
  11. 11

    Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses by Rojas, Juan J, Guedan, Sonia, Searle, Peter F, Martinez-Quintanilla, Jordi, Gil-Hoyos, Raúl, Alcayaga-Miranda, Francisca, Cascallo, Manel, Alemany, Ramon

    Published in Molecular therapy (01-11-2010)
    “…Oncolytic adenoviruses are promising anticancer agents due to their ability to self-amplify at the tumor mass. However, tumor stroma imposes barriers difficult…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Ras-dependent oncolysis with an adenovirus VAI mutant by CASCALLO, Manel, CAPELLA, Gabriel, MAZO, Adela, ALEMANY, Ramon

    Published in Cancer research (Chicago, Ill.) (01-09-2003)
    “…Adenovirus synthesize proteins that interact with oncogene and tumor suppressor gene products to set the cell for virus replication. Mutant viruses defective…”
    Get full text
    Journal Article
  15. 15

    Adeno-associated virus enhances wild-type and oncolytic adenovirus spread by Laborda, Eduardo, Puig-Saus, Cristina, Cascalló, Manel, Chillón, Miguel, Alemany, Ramon

    Published in Human gene therapy. Part B. Methods (01-12-2013)
    “…The contamination of adenovirus (Ad) stocks with adeno-associated viruses (AAV) is usually unnoticed, and it has been associated with lower Ad yields upon…”
    Get more information
    Journal Article
  16. 16

    Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy by Martinez-Quintanilla, Jordi, Cascallo, Manel, Gros, Alena, Fillat, Cristina, Alemany, Ramon

    Published in Molecular cancer therapeutics (01-11-2009)
    “…Thymidine kinase (TK)-mediated suicide gene therapy has been considered for the treatment of pancreatic cancer. However, despite a bystander effect, the…”
    Get full text
    Journal Article
  17. 17

    Anti-migratory and anti-angiogenic effect of p16 : A novel localization at membrane ruffles and lamellipodia in endothelial cells by ALHAJA, Elena, ADAN, Jaume, PIULATS, Jaume, PAGAN, Roser, MITJANS, Francesc, CASCALLO, Manel, RODRIGUEZ, Mercè, NOE, Veronique, CIUDAD, Carlos J, MAZO, Adela, VILARO, Senen

    Published in Angiogenesis (London) (01-12-2004)
    “…Recent evidence has established different functions for the tumor suppressor protein, p16(INK4A) aside from controlling the cell cycle. Here we report that…”
    Get full text
    Journal Article
  18. 18

    Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors by Cascalló, Manel, Calbó, Joaquim, Capellà, Gabriel, Fillat, Cristina, Pastor-Anglada, Marçal, Mazo, Adela

    Published in Oncology (01-01-2005)
    “…Human pancreatic adenocarcinomas are highly resistant to conventional treatment modalities, specially to chemotherapy. Among the genes that modulate apoptosis…”
    Get more information
    Journal Article
  19. 19

    Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer by Calbó, J, Marotta, M, Cascalló, M, Roig, J M, Gelpí, J L, Fueyo, J, Mazo, A

    Published in Cancer gene therapy (01-10-2001)
    “…Pancreatic cancer has long carried poor prognosis. The development of new therapeutic approaches is particularly urgent. Inactivation of the tumor-suppressor…”
    Get full text
    Journal Article
  20. 20

    Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer by Cascalló, M, Calbó, J, Gelpí, J L, Mazo, A

    Published in Cancer gene therapy (01-04-2000)
    “…Chemotherapy does not significantly improve prognosis in pancreatic cancer. New therapeutical approaches involving p53 gene replacement appear to be very…”
    Get full text
    Journal Article